LCZ696 Intermedia CAS 1426129-50-1 Puritas ≥98.0% (HPLC) ee ≥99.0% Factory High Purity
Commercial Supple LCZ696 (CAS: 936623-90-4) Intermedia:
(R)-tert-Butyl (1-([1,1-biphenyl]-4-yl) -3-hydroxypropan-2-yl) carbamatum CAS: 1426129-50-1
(R, E) -5-(1,1'-biphenyl-4-yl) -4-((tert-butoxycarbonyl)amino) -2-methylpent-2-enoicum acidum CAS: 1012341-48-8
(2R,4S) -5-(1,1'-biphenyl-4-yl) -4-((tert-butoxycarbonyl)amino) -2-acidi methylpentanoici CAS: 1012341-50-2
(2R,4S)-ethyl 5-(1,1'-biphenyl-4-yl) -4-amino-2-methylpentanoate HCl CAS: 149690-12-0
AHU-377 (salis hemicalcium) CAS: 1369773-39-6
AHU-377;Sacubitril CAS: 149709-62-6
LCZ696;Triticum aestivum;Sacubitrile mixtum cum Valsartano CAS: 936623-90-4
| Nomen chemicum | (R) -tert-Butyl (1-([1,1-biphenyl]-4-yl) -3-hydroxypropan-2-yl) carbamate |
| Synonyma | LCZ696 Medium |
| CAS Number | 1426129-50-1 |
| CATTUS Number | RF-PI169 |
| Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
| Formulae hypotheticae | C20H25NO3 |
| M. Pondus | 327.42 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba ad Off-White pulveris |
| Puritas / Analysis Methodus | ≥98.0% (HPLC) |
| Enantiomeric Excessus | ee: ≥99.0% |
| Humor (KF) | ≤1.0% |
| Substantiae cognatae A | ≤1.0% (RRT=0.5)A=(R)-3-([1,1'-biphenyl]-4-yl)-2-aminopropan-1-ol |
| Substantiae cognatae B | ≤1.0% (RRT=0.85) B=Triphenylphosphinum oxydatum |
| Aliae substantiae | ≤1.0% |
| Totalis immunditias | ≤2.0% |
| Test Standard | Enterprise Standard |
| Consuetudinem | Medium LCZ696 (CAS: 936623-90-4) in curatione HFrEF |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.
Manufacturer cum High puritate et stabulo Quality
Commercial Supple LCZ696 (CAS: 936623-90-4) Intermedia:
(R)-tert-Butyl (1-([1,1-biphenyl]-4-yl) -3-hydroxypropan-2-yl) carbamatum CAS: 1426129-50-1
(R, E) -5-(1,1'-biphenyl-4-yl) -4-((tert-butoxycarbonyl)amino) -2-methylpent-2-enoicum acidum CAS: 1012341-48-8
(2R,4S) -5-(1,1'-biphenyl-4-yl) -4-((tert-butoxycarbonyl)amino) -2-acidi methylpentanoici CAS: 1012341-50-2
(2R,4S)-ethyl 5-(1,1'-biphenyl-4-yl) -4-amino-2-methylpentanoate HCl CAS: 149690-12-0
AHU-377 (salis hemicalcium) CAS: 1369773-39-6
AHU-377;Sacubitril CAS: 149709-62-6
LCZ696;Triticum aestivum;Sacubitrile mixtum cum Valsartano CAS: 936623-90-4
LCZ696 experimentum medicamentum a Novartis pharmaceuticis in Civitatibus Foederatis Americae ad effectum deductum est ad curationem aegrorum Cordis Defectum cum reducta Eiectione Fraction (HFrEF).Animi defectus est vita-minas morbus.Cor aegri non satis sentinam sanguinis ad corpus supplendum, et apparent indicia dyspnoeae, lassitudines et retentio fluidorum lente, paulatim aucta, significanter qualitatem vitae afficit.LCZ696 defensionem naturalem corporis contra defectum cordis augere potest, necnon gradum peptidum natriureticae et aliorum peptidum vasoactivorum endogenorum augere, et systematis renin-angiotensin-aldosterone (RAAS).LCZ696 cum Hypertensione Novartis Medication (Diovan, nomen genericum: valsartan) et experimentum medicamento AHU-377 coniunxit.AHU377 mechanismum impedit duorum peptidum author pressurae sanguinis minuendae.Diovan vasodilatationem meliorem facit et corpus ad natrium et aquam excernendum excitat.
